Clinical and genetic characterization of limb-girdle muscular dystrophy 2G/R7 in a large cohort of Brazilian patients
Jonas Alex Morales Saute(Hospital de Clínicas de Porto Alegre), Tobias Gaviraghi(Universidade Federal do Rio Grande do Sul), Paulo Victor Sgobbi de Souza(Universidade Federal de São Paulo), Eduardo Boiteux Uchôa Cavalcanti(Sarah Network of Rehabilitation Hospitals), Cláudia Ferreira da Rosa Sobreira(Universidade de São Paulo), Paulo José Lorenzoni(Universidade Federal do Paraná), Marcondes C. França(National Hospital for Neurology and Neurosurgery), Elmano Carvalho(Grupo Santa Casa de Belo Horizonte), Alzira Alves de Siqueira Carvalho(Centro Universitário Fundação Santo André)
Cited by 0
Related Papers
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
|The Lancet Neurology|2017|820
<i>D</i><scp><i>NAJC</i></scp><i>6</i><scp>M</scp>utations <scp>A</scp>ssociated <scp>W</scp>ith <scp>E</scp>arly‐<scp>O</scp>nset <scp>P</scp>arkinson's <scp>D</scp>isease
|Annals of Neurology|2015|208
Mitochondrial encephalomyopathy with coenzyme Q <sub>10</sub> deficiency
|Neurology|1997|196
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy
|Brain|2015|142
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
|Neuromuscular Disorders|2017|128